Dr. Sudhir Nambiar

With increase in population, the growth of the middle class is imminent and almost 100 million people will be added in the next few years. This means that the buying power will increase and both the agro and pharma side are going to see the benefits. There are significant shifts and new trends are emerging, consumers are getting more demanding – both in the area of pharma and agro chemicals. There are also a few challenges in India; one is related to IPR, significant barriers for the growth of multinational companies and local pharma companies. Price control is yet another issue in terms of agro-chem industry.
We have done well in the generic space, in terms of discovery we have been abysmally poor. We have an increasing number of deaths due to tropical diseases but not many medicines are discovered to tackle this problem.